Tag archive for ‘Clinical Research’

Teva launches generic migraine treatment

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has launched generic treatment is for migraine, Axert (almotriptan malate) tablets in 6.25 mg and 12.5 mg dosages, in the US. Teva is the first More...

Gil Tanenbaum On Sunday, June 28th, 2015

Google Developing Wristband to Replace Doctors

– – Not to be outdone by Apple, Google is developing its own watch. Only this one will tell you your blood pressure, heart rate, and other things instead of the time. The company gave the scoop More...

Jewish Business News On Thursday, February 26th, 2015

RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage

RegeneRx Biopharmaceuticals, Inc, an American publicly traded, clinical-stage, biopharmaceutical company, has received an Israeli patent with claims for preventing, inhibiting or reducing heart tissue More...

Jewish Business News On Wednesday, December 17th, 2014

Clinical Trial Shows Healthy Eaters Can Ignore the Glycemic Index

Good news for people who are already following a diet rich in fruits, vegetables and whole grains, and low in sweets: New research suggests these heart-healthy eaters don’t need to worry about choosing More...

Zami Aberman Pluristem

Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints

Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR), a leading developer of placenta-based cell therapies, today announced top-line results from its Phase I/II clinical trial testing the safety More...

Wordpress site Developed by Fixing WordPress Problems